Large-scale testing (Phase 3)Study completedNCT01894919
What this trial is testing
Antibody Persistence, and Safety and Tolerability of a Booster Dose of the Meningococcal B Vaccine After the Completion of the Vaccination Course in Study V72_28
Who this might be right for
Meningoccocal DiseaseMeningococcal Meningitis
Novartis Vaccines 851